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Local anesthetics do not penetrate readily through
human skin if applied in their salt form; however, if
applied in their base form, various effects may be
observed, such as a decrease in pricking pain and a
change in burning, itch, and thermal sensations. These
effects occur after skin penetration and may be attrib-
uted to the action of the anesthetics on nociceptors
and thermoreceptors, i.e., on C and Ad nerve fiber
respectively. As there is little known about the time
course of the pharmacodynamic response of cutane-
ously applied local anesthetic bases, this study was
conducted to characterize various local anesthetics
pharmacodynamically by measuring thermal thresh-
olds over time with a thermal sensory analyzer. The
results show that the investigated local anesthetics
affect thermal thresholds to a different extent, with
Topical local anesthetic preparations are widely availableas over-the-counter remedies. Such products areusually intended for anesthesia of mucosal epitheliaand of broken or abraded skin. They are almostwithout effect on healthy skin where the chemical
barrier function of the stratum corneum remains intact; however,
if certain anesthetics are applied to healthy skin in their base form
rather than the more usual, water soluble salts, effects may be
observed, such as a decrease in pricking pain (McCafferty et al,
1988; Woolfson and McCafferty, 1993), a reduction of the flare
response to histamine (Pipkorn and Andersson, 1987), and a change
in burning, itch, and thermal sensations (Adriani and Dalili, 1971;
Yosipovitch and Maibach, 1997). These effects are due to the
action of the anesthetics on nociceptors and thermoreceptors, i.e.,
on C and Aδ nerve fibers, respectively. With the introduction of
the eutectic mixture of lidocaine and prilocaine (EMLA) and the
phase change system consisting of tetracaine in a xanthan gum gel
(Ametop), effective percutaneous local anesthesia is feasible.
As the skin is richly provided with sensory nerve fibers, quantita-
tive sensory testing such as the assessment of vibration, light touch,
thermal sensations, and pain thresholds is a useful procedure not
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tetracaine and lidocaine being most efficient. From
the response versus time profiles of all eight study
subjects, various response parameters were obtained:
only the cold sensation parameters proved suitable
for characterization of the local anesthetics, possibly
because cold receptors are located in the epidermis
and can easily be reached. Lag times of onset are short
and the maximum anesthetic effect is reached within
2–3 h. Cold sensation parameters correlate linearly
with the solubility of the local anesthetic bases in
medium chain triglycerides and with the drug flux of
50% saturation, indicating that medium chain tri-
glycerides may have similar properties with regard to
the local anesthetics solubility as the stratum corneum
lipids. Key words: parameter of response/physico-chemical
parameters/stratum corneum lipids/thermal sensation. J
Invest Dermatol 113:304–307, 1999
only for diagnostic purposes but also for the investigation of the
effect of topical drugs on sensory perception (Yosipovitch et al,
1996a,b, 1997; Yosipovitch and Maibach, 1997). Thermal sensory
testing is becoming an important quantitative sensory testing
technique because it allows the investigation of small nerve fiber
function, which cannot be evaluated by nerve conduction velocity
tests (Yosipovitch and Yarnitsky, 1996). Thermal sensory testing
allows the measurement of the effect of drugs on both thermal
sensations and thermal pain thresholds. If a peltier device such as a
thermal sensory analyzer is used as a testing instrument, the effect
of topically applied local anesthetics on cold and warm sensations
as well as on thermal pain thresholds may be determined
(Yosipovitch and Yarnitsky, 1996). As there is little known about
the time course of the pharmacodynamic response of cutaneously
applied local anesthetic bases, this study was conducted to character-
ize various anesthetics pharmacodynamically by measuring thermal
thresholds over time with a thermal sensory analyzer.
MATERIALS AND METHODS
Preparation of local anesthetic bases (LA) Fomocaine-HCl
(Engelhard, Frankfurt am Main, Germany), benzocaine (Ritsert, Eberbach,
Germany), tetracaine-HCl (Mann, Berlin, Germany), lidocaine-HCl (Astra,
Wedel, Germany), etidocaine-HCl (Astra, Wedel, Germany), and cart-
icaine-HCl (Hoechst, Frankfurt am Main, Germany) were used to prepare
the LA. The bases were obtained by dissolving the hydrochlorides in
distilled water and adjusting the pH to 10 with 3 M sodium hydroxide.
Subsequently, the LA were extracted three times with diethyl ether. The
combined fractions were dried with anhydrous sodium sulfate, evaporated
to dryness after filtration, and stored in a desiccator under a vacuum for
2 d. All six LA are solid at room temperature. Only one melting peak was
detected by DSC and in HPLC chromatograms one sharp peak was found
with each of the LA even after 2.5 y of storage.
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Measurement of the pharmacodynamic response The study was
approved by the Ethics Committee of the School of Medicine of the
University of California at San Francisco. Eight healthy volunteers (age
25–65 y) provided written informed consent to participate. They received
all six LA, one at a time and 7 d apart.
According to their solubility the LA were dissolved in either methylene
chloride (fomocaine, benzocaine, tetracaine, carticaine) or ethanol (lido-
caine, etidocaine) at a concentration of 100 mg per ml and 1 ml of each
solution was applied to an area of 3.5 3 3.5 cm2 on the volar aspect
of the forearm with an insulin syringe. To guarantee the maximum
thermodynamic LA activity and to avoid a barrier-modifying action of the
solution media the solvents were allowed to evaporate. Cold and warm
sensations (CS, WS) as well as cold and heat pain thresholds (CP, HP)
were measured non-invasively on the uncovered application sites with a
thermal sensory analyzer (TSA 2001, Medoc U.S., Minneapolis, MN).
The instrument was equipped with a thermode (size 3 3 3 cm2) adjusted
to an adaptation temperature of 33°C, which caused occlusion of the
application site as it remained on the skin for 4–5 h. Control measurements
were done immediately before application of the LA and thresholds were
recorded starting 15 min after LA application using the method of limits
as test algorithm (Yosipovitch and Yarnitsky, 1996). With this method,
stimuli increase continuously in intensity until the requested sensation is
perceived, at which moment the stimulus is halted by the subject and the
thermode temperature returns to adaptation temperature. A reaction time
artifact is built in this measurement. All subjects were trained in CS, WS,
CP, and HP perception before starting the experiment to minimize the
intersession bias and to achieve acceptable repeatability (Yarnitsky and
Sprecher, 1994).
Thermal thresholds were obtained in the following manner. In session
I, only WS and CS were measured every 5 min over 4–5 h until constant
thresholds were achieved. Six oscillating stimuli starting with WS were
given at a constant temperature rate of 0.3°C and with a time interval of
5 s between stimuli. In session II, 1 d later, HP and CP were measured
on the contralateral side every 10 min. The six oscillating stimuli were
given with a temperature rate of 0.5°C, a return rate to adaptation
temperature of 10°C, and time intervals between the stimuli of 10 s.
Sessions were held in a sound-proof air-conditioned room, with distractions
minimized. Subjects did not have visual access to the computer screen; no
visual or auditory cues were given to signal stimulus onset. WS and CS as
well as HP and CP means were calculated automatically by the Medoc
software for each cluster of stimuli.
In preliminary experiments no significant effect of stimulus repetition
on thermal thresholds measured over 5 h under the above-mentioned
conditions could be detected.
From the thermal thresholds versus time profiles the following response
parameters were obtained: the maximum change in CS and CP (∆ CS, ∆
CP) as intensity-related parameters, the CS slope as a combined time- and
intensity-related parameter, and the lag time of onset of the anesthetic
action. ∆ CS and ∆ CP were calculated as the differences between the
baseline and the minimum thresholds. Statistical significance (p 5 0.05) of
these differences was confirmed with a paired t test. Minimum thresholds
correspond to the means of the last five data points whereas the baseline
thresholds represent the means of the first four data points including the
control value. As the standard deviations of these data points are small in
comparison with the intersubject variations, they were assumed to be
negligible. The slope of the curves was determined by linear regression
analysis, as the decrease in CS over time appeared to be linear (correlation
coefficients between 0.95 and 0.98). All data points that exceeded the
range of variation of the first four and the last five data points were
included in the regression analysis. The lag times of onset were determined
as the time points of intersection of the mean baseline plateau and the CS
regression lines.
Measurement of the steady-state drug flux Drug penetration meas-
urements were done with a glass cell system (Leopold and Lippold, 1992,
1995). This method allows the measurement of even small drug fluxes by
the difference method (Stricker et al, 1987). Etidocaine, benzocaine,
lidocaine, and tetracaine were dissolved in the inert non-irritating vehicle
purified light mineral oil (Parafluid Mineralo¨lgesellschaft, Hamburg,
Germany) at concentrations that correspond to 50% of the LA solubility
in this vehicle (etidocaine, 852.8 mg per 100 ml; benzocaine, 60 mg per
100 ml; lidocaine, 2419.6 mg per 100 ml; tetracaine, 1037.7 mg per
100 ml). The four drug solutions were applied to the upper arms of six
healthy subjects and examined under occlusive conditions because of the
closed system over 6 h. After a 1 h pretreatment period with the vehicle,
each glass cell was filled with one of the drug solutions, emptied after 1
or 2 h and refilled with the initial drug solution. Zero order kinetics were
assumed because the concentration decrease in each 2 h time interval was
Figure 1. Thermal thresholds versus time. Typical thresholds of cold
and warm sensations (CS, WS) and cold and heat pain (CP, HP) versus
time profiles after application of various LA to forearm skin at maximum
thermodynamic activity (subject LR)
,10%, with the exception of the tetracaine solution which for this reason
had to be replaced at 1 h time intervals. The concentration of the donor
phase samples was measured spectrophotometrically (Lambda 2, Perkin-
Elmer, U¨berlingen, Germany), in 0.1 cm quartz cells at wavelengths that
provided an UV absorption between 0.9 and 1.0 of the initial solutions.
LA disappearance rates per area unit were calculated from the concentration
differences between the initial solution and the samples obtained after
every 1 or 2 h, multiplied by the volume of the respective cells, and
divided by the application area and the time interval. Steady state, indicated
by the constant drug disappearance rates, was reached after approximately
2–4 h with all subjects. For further data analysis only the six h values
were used.
Steady-state drug disappearance rates per area unit are referred to as
‘‘Drug flux of 50% saturation (Jmax 50%)’’ throughout this paper.
RESULTS AND DISCUSSION
Typical thermal thresholds versus time profiles for the investigated
LA are shown in Fig. 1. It is obvious from these curves that the
investigated LA affect thermal thresholds to a different extent, with
tetracaine and lidocaine being the most efficient LA. Interestingly,
a similar observation has been made after topical application of
several LA in an o/w cream base at an equimolar concentration
instead of equal thermodynamic drug activity (McCafferty et al,
1988). Lidocaine and tetracaine were more effective at producing
local anesthesia to the challenge of insertion of a needle into the
ventral forearm skin than benzocaine and fomocaine. The same
tendency was observed with the steady-state flux values and
permeability coefficients through Silastic membrane.
According to the thermal thresholds versus time profiles in Fig 1,
CS and WS appear to change linearly over time, a relationship also
found with argon laser-induced cutaneous pain after application of
EMLA cream (Bjerring and Arendt-Nielsen, 1990). Note that 30–
60 min after tetracaine application six of the eight subjects developed
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Table I. Overview of response parametersa
Fomocaine Benzocaine Tetracaine Lidocaine Etidocaine Carticaine
Lag time of onset [h] 0.52 6 0.07 0.61 6 0.08 0.86 6 0.11 1.01 6 0.16 2.32 6 0.22 2.30 6 0.29
CS slope [°C per min] 0.136 6 0.031 0.051 6 0.008 0.341 6 0.041 0.189 6 0.019 0.006 6 0.004 0.087 6 0.016
∆ CS [°C] 12.7 6 2.3 4.5 6 1.0 27.0 6 3.5 16.1 6 2.2 1.7 6 0.4 6.9 6 1.6
∆ CP [°C] 20.2 6 2.2 7.7 6 0.9 28.7 6 2.6 23.4 6 0.9 7.8 6 0.5 5.5 6 1.0
aLag time of onset of local anesthesia, rate of change in cold sensation (CS slope, displayed as positive values), and maximum change in cold sensation and cold pain (∆
CS, ∆ CP) determined from the thermal thresholds versus time profiles of eight subjects. LA were applied to forearm skin at their maximum thermodynamic activity. Means
6 SD, n 5 8 subjects.
Figure 2. Pharmacodynamic response versus LA solubility. Maximum
change in cold sensation (∆ CS) and the rate of change in cold sensation
(CS slope) after application of various LA to forearm skin at maximum
thermodynamic activity as a function of the LA solubility in medium chain
triglycerides (MCT). Means 6 SD, n 5 8 subjects
erythema in combination with itching and edema at the application
site; however, these known adverse effects of tetracaine, caused by
vasodilation and histamine release (Willats and Reynolds, 1985;
Lawson et al, 1995), disappeared within 2–3 h after application and
did not affect thermal thresholds.
Table I provides an overview of the response parameters obtained
from the individual curves of all eight subjects. ∆ CS and CS slope
appeared suitable parameters for the pharmacodynamic characteriza-
tion of the LA, possibly because cold receptors are located in the
epidermis (Bazett et al, 1930) and can easily be reached by LA. In
contrast, warm receptors are located deeper in the dermis (Zotter-
man, 1959) and warmth- and heat-related response parameters such
Figure 3. Pharmacodynamic response versus LA flux. Maximum
change in cold sensation (∆ CS) and the rate of change in cold sensation
(CS slope) versus Jmax 50%. Means 6 SD, n 5 6 subjects
as the maximum change in WS and HP, as well as the WS slope,
were not useful for characterization of the LA. HP appeared to be
unaffected and the maximum WS in most cases correspond to the
HP threshold plateaus, i.e., ∆ WS does not differ significantly
among the LA. A similar observation has recently been made with
pramoxine lotion 1%, where no effect on WS and HP but a
significant change in CP thresholds was found after application for
30 min (Yosipovitch and Maibach, 1997). The fact that CS is
mediated by myelinated Aδ fibers in contrast to WS, which is
transmitted by unmyelinated and therefore better accessible C
fibers, does not appear to affect the pharmacodynamic response.
CP thresholds are difficult to evaluate because with potent
LA such as lidocaine and tetracaine the minimum instrument
temperature of 0°C is reached, which makes it impossible to
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distinguish between these compounds. Moreover, instead of feeling
cold pain many subjects felt a light pricking sensation after onset
of anesthesia, which explains the high intrasubject variability in CP
thresholds (Fig 1).
The lag times of onset, differing between 0.5 and 2.3 h, have
in the past been shown to be suitable response parameters only if
one model drug is looked at (Le, 1993); however, the values
for lidocaine and tetracaine correspond to the recommended
pretreatment periods for EMLA cream and Ametop gel, respectively.
The maximum anesthetic effect is reached within 2–3 h with all
LA. If the CS response data are correlated with physicochemical
parameters such as LA lipophilicity, solubility in various solvents,
degree of dissociation, protein binding, relative potency, or the
ability to change the packing order of the stratum corneum lipids,
a correlation may be observed only with the LA solubility in
medium chain triglycerides (MCT), consisting of caprylic/capric
acid triglycerides (Fig 2). Surprisingly, no correlation was found
with the relative LA potency, even if a combined parameter such
as the product of the LA potency and Jmax 50% was used. Etidocaine,
a highly potent LA, affects thermal sensations only marginally,
which may be attributed to the low drug flux through stratum
corneum. Obviously LA penetration through the barrier stratum
corneum is the rate-limiting step and determines the pharmaco-
dynamic effect of percutaneously applied LA. A possible explanation
for the linear relationship between the CS response data and the
LA solubility in MCT is that MCT represents a solvent with
properties similar to the stratum corneum lipids. If this is true, the
response should also correlate linearly with Jmax 50%. In Fig 3, CS
response data are plotted versus Jmax 50% of eticocaine, benzocaine,
lidocaine, and tetracaine from light mineral oil as vehicle. The
relationship between the CS response data and Jmax 50% is indeed
linear, which supports the above-mentioned theory. The x axis
intercepts of the regression lines in Fig 3 do not significantly differ
from zero, in contrast to the plots in Fig 2, where x axis intercepts
of about 0.3 mol per litre are obtained, indicating that apparently
minimum solubility is required to observe an effect. A possible
explanation for these intercepts is that the response data as well as
the drug flux data not only depend on the solubility of the drug
in the barrier but also on the drug diffusion coefficient. LA affect
the structure of the lipids in biomembranes (Seeman, 1972).
Tetracaine and lidocaine are able to fluidize the lipid bilayers in
the stratum corneum (Woolfson et al, 1991; Ro¨mmen et al, 1998),
a process that may lead to an increase of the drug diffusion in the
barrier. Other anesthetics such as ketamine increase the packing
order of the stratum corneum lipids, leading to a decrease in the
diffusion coefficient (Ro¨mmen et al, 1998). It may, therefore, be
possible that the x axis intercepts in Fig 2 are the result of an
increase in slope and a shift of the regression lines due to the
different effects of LA on the packing order of the stratum corneum
lipids and thus the diffusion coefficient in the barrier.
Taken together it may be concluded that cutaneously applied
LA are able to penetrate through human skin and affect thermal
thresholds. Lag times of onset are short and the maximum anesthetic
effect is reached within 2–3 h. CS parameters are the most suitable
response parameters and they may be correlated with the solubility
of the LA in MCT and Jmax 50%, indicating that MCT has similar
properties with regard to LA solubility as stratum corneum lipids.
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